These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12137082)

  • 1. The invisible hand of the marketing department.
    CMAJ; 2002 Jul; 167(1):5, 7. PubMed ID: 12137082
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic-class wars--drug promotion in a competitive marketplace.
    Kessler DA; Rose JL; Temple RJ; Schapiro R; Griffin JP
    N Engl J Med; 1994 Nov; 331(20):1350-3. PubMed ID: 7935706
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug companies, doctors and disclosures.
    Tuorto S; Chan MK; Adusumilli PS
    Natl Med J India; 2004; 17(4):215-6. PubMed ID: 15372772
    [No Abstract]   [Full Text] [Related]  

  • 4. Competitive dynamics in pharmaceuticals.
    Murphy MN; Smith MC; Barnes JH; Szeinbach SL
    J Health Care Mark; 1995; 15(2):24-33. PubMed ID: 10144664
    [No Abstract]   [Full Text] [Related]  

  • 5. Stop the dollar worshiping.
    Keller BR
    Tex Med; 2001 Feb; 97(2):13-4. PubMed ID: 11233053
    [No Abstract]   [Full Text] [Related]  

  • 6. Big pharma and American psychiatry.
    Sharfstein SS
    J Nerv Ment Dis; 2008 Apr; 196(4):265-6. PubMed ID: 18414119
    [No Abstract]   [Full Text] [Related]  

  • 7. Tough enough? Rules about drug firms' gifts get new look from docs.
    Romano M
    Mod Healthc; 2004 Jul; 34(27):16. PubMed ID: 15279115
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rules of the game in drug marketing].
    Palva E
    Duodecim; 1999; 115(20):2187, 2189. PubMed ID: 11973920
    [No Abstract]   [Full Text] [Related]  

  • 9. Competition. Marketing your practice--how it can be ethical.
    Shahady EJ
    Consultant; 1987 Mar; 27(3):90-2. PubMed ID: 10289999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug promotion.
    Mossinghoff GJ
    N Engl J Med; 1995 Apr; 332(15):1032; author reply 1033. PubMed ID: 7885415
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug marketing exclusivity under United States and European Union law.
    Junod V
    Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug promotion.
    La Puma J
    N Engl J Med; 1995 Apr; 332(15):1031; author reply 1033. PubMed ID: 7885413
    [No Abstract]   [Full Text] [Related]  

  • 13. Tarnishing the medical profession's image.
    Sivarajan M
    N Engl J Med; 1985 Apr; 312(17):1132. PubMed ID: 3982477
    [No Abstract]   [Full Text] [Related]  

  • 14. Take a meeting. Drug firms hosting many more events for docs.
    Romano M
    Mod Healthc; 2001 Jul; 31(29):9. PubMed ID: 11484239
    [No Abstract]   [Full Text] [Related]  

  • 15. The creation of the medical consumer.
    Berg TL
    S D Med; 2008 Feb; 61(2):42. PubMed ID: 18432148
    [No Abstract]   [Full Text] [Related]  

  • 16. How Zantac became the best-selling drug in history.
    Wright R
    J Health Care Mark; 1996; 16(4):24-9. PubMed ID: 10169076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1983: the year in review. The national view: Canada Health Act looms large.
    Can Med Assoc J; 1984 Jan; 130(1):61-70. PubMed ID: 6689991
    [No Abstract]   [Full Text] [Related]  

  • 18. The new drug war.
    Parloff R
    Fortune; 2004 Mar; 149(5):144-6, 148, 150 passim. PubMed ID: 15015428
    [No Abstract]   [Full Text] [Related]  

  • 19. [European drug policy: welcomed modernization but shortage of political proposals concerning industry and research].
    Alván G
    Lakartidningen; 2003 Oct; 100(44):3541-2. PubMed ID: 14651017
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotech jostles with pharma for slice of HIV market.
    Katsnelson A
    Nat Biotechnol; 2006 Jan; 24(1):3-4. PubMed ID: 16404375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.